Get the Stockscreener App
0.1215
1.25%
0.0015
After Hours:
.12
-0.0015
-1.23%
AEON Biopharma Inc. stock is traded at $0.1215, with a volume of 2.20M.
It is up +1.25% in the last 24 hours and down -78.30% over the past month.
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.
See More
Previous Close:
$0.12
Open:
$0.1225
24h Volume:
2.20M
Relative Volume:
0.15
Market Cap:
$9.80M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-5.08%
1M Performance:
-78.30%
6M Performance:
-93.77%
1Y Performance:
-98.32%
1-Day Range:
$0.1179
$0.123
1-Week Range:
$0.115
$0.1531
52-Week Range:
$0.1013
$17.17
AEON Biopharma Inc. Stock (AEON) Company Profile
Name
AEON Biopharma Inc.
Sector
Industry
Phone
(949) 354-6499
Address
5 Park Plaza, Suite 1750, Irvine
Compare AEON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
0.1215 | 9.80M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 113.67B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 74.97B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.68 | 40.50B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.95B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
120.88 | 29.63B | 3.30B | -501.07M | 1.03B | -2.1146 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-18-23 | Initiated | H.C. Wainwright | Buy |
AEON Biopharma Inc. Stock (AEON) Latest News
Midday Stock Roundup: FivePoint Holdings Jumps 36% - Orange County Business Journal
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Kairos, OS Therapies, AEON See Highest Weekly Spike In Retail Following Among Biotechs: Here's Why - NewsBreak
Irvine-based Aeon Biopharma Raises $20 Million - Orange County Business Journal
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Dow Jumps Over 300 Points; US Industrial Production Beats Estimates - Benzinga
Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Benzinga
AEON Biopharma Inc (AMEX: AEON) -9.93% Decline Turns Investors Away - Stocks Register
AEON Biopharma (NASDAQ:AEON) Stock Price Down 9.9% – What’s Next? - Defense World
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
AEON Stock Plummets to 52-Week Low at $0.16 Amid Market Turbulence - Investing.com
AEON’s Value Tanks As It Closes $20m Offering Amid Botox Biosimilar Aspirations - News & Insights
AEON Biopharma announces share offering - MSN
AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering - The Manila Times
AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering - Benzinga
AEON Biopharma Raises $20M in Public Offering with Dual-Warrant Structure - StockTitan
Form 424B5 AEON Biopharma, Inc. - StreetInsider.com
AEON Biopharma sets $20 million public offering pricing By Investing.com - Investing.com Nigeria
Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet - Benzinga
Stock market news: Boxlight increased by 284.78% while AEON Biopharma declined by 66.75% during mid day trading - Business Upturn
S&P Jumps 1%; Regional Health Properties Shares Spike Higher - Benzinga
Why AEON Biopharma Stock Is Down 65% Today - Benzinga
US Stocks Open Higher; Dow Jumps Over 200 Points - Benzinga
Stock market today: AEON Biopharma saw gain of 255.62% while SciSparc increased by 89.77% in early trading - Business Upturn
Aeon Biopharma prices 40M units at 50c in underwritten public offering - TipRanks
AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering - The Manila Times
Why Smart Share Global Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket - Benzinga
AEON Biopharma, Inc. Announces Launch of Proposed Public Offering - The Manila Times
Feeder Cattle (GFH20) Quote - The Globe and Mail
AEON Biopharma Announces Public Offering of Common Stock and Warrants with Aegis Capital - StockTitan
Boeing Company (BA-N) QuotePress Release - The Globe and Mail
Nvidia Corp (NVDA-Q) QuotePress Release - The Globe and Mail
AEON Biopharma (NASDAQ:AEON) & Newron Pharmaceuticals (OTCMKTS:NWPHF) Financial Review - Defense World
Head to Head Survey: AEON Biopharma (AEON) & Its Peers - Defense World
AEON Biopharma (AEON) vs. Its Peers Critical Survey - Defense World
Comparing AEON Biopharma (AEON) & Its Competitors - Defense World
Entergy Corp (ETR-N) QuotePress Release - The Globe and Mail
Amkor Technology (AMKR-Q) QuotePress Release - The Globe and Mail
Carvana Company Cl A (CVNA-N) QuotePress Release - The Globe and Mail
Migraine Market Forecasted to Surge in Coming Years, 2023-2032 Analysis by DelveInsight | Amgen, Teva Pharma, Eli Lilly, Teva Pharma, Axsome Therapeutics, AEON Biopharma, Charleston Laboratories - Barchart
TSX Global Mining Index (TXGM) QuotePress Release - The Globe and Mail
OC500 2024: Tom Schoenherr - Orange County Business Journal
Blue Owl Capital Holdings LP Acquires New Stake in AEON Biopharm - GuruFocus.com
AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update - The Manila Times
AEON Biopharma : Reports Third Quarter 2024 Financial Results and Provides Corporate Update Form 8 K - Marketscreener.com
AEON Biopharma Advances BOTOX Biosimilar Development, Secures FDA Meeting Milestone | AEON Stock News - StockTitan
Kailera Therapeutics Appoints Scott M. Akamine as Chief Legal Officer - GlobeNewswire
Broadcom Corp (BRCM-Q) QuotePress Release - The Globe and Mail
Mondelez Intl Inc (MDLZ-Q) QuotePress Release - The Globe and Mail
Uber Technologies Inc (UBER-N) QuotePress Release - The Globe and Mail
AEON Biopharma Inc. Stock (AEON) Financials Data
There is no financial data for AEON Biopharma Inc. (AEON). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
5.49%
0.79%
Cap:
|
Volume (24h):